» Articles » PMID: 34147932

Efficacy of Non-invasive Brain Stimulation in Decreasing Depression Symptoms During the Peripartum Period: A Systematic Review

Abstract

Background: Non-invasive brain stimulation (NIBS) techniques have been suggested as alternative treatments to decrease depression symptoms during the perinatal period. These include brain stimulation techniques that do not require surgery and that are nonpharmacological and non-psychotherapeutic. NIBS with evidence of antidepressant effects include repetitive transcranial magnetic stimulation (rTMS), transcranial electric stimulation (TES) and electroconvulsive therapy (ECT).

Objectives: This systematic review aims to summarize evidence on NIBS efficacy, safety and acceptability in treating peripartum depression (PPD).

Methods: We included randomized, non-randomized and case reports, that used NIBS during pregnancy and the postpartum. The reduction of depressive symptoms and neonatal safety were the primary and co-primary outcomes, respectively.

Results: rTMS shows promising results for the treatment of PPD, with clinically significant decreases in depressive symptoms between baseline and end of treatment and overall good acceptability. Although the safety profile for rTMS is adequate in the postpartum, caution is warranted during pregnancy. In TES, evidence on efficacy derives mostly from single-arm studies, compromising the encouraging findings. Further investigation is necessary concerning ECT, as clinical practice relies on clinical experience and is only described in low-quality case-reports.

Limitations: The reduced number of controlled studies, the lack of complete datasets and the serious/high risk of bias of the reports warrant cautious interpretations.

Conclusions And Implications: Existing evidence is limited across NIBS techniques; comparative studies are lacking, and standard stimulation parameters are yet to be established. Although rTMS benefits from the most robust research, future multicenter randomized clinical trials are needed to determine the position of each NIBS strategy within the pathways of care.

Citing Articles

Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology.

Trapp N, Purgianto A, Taylor J, Singh M, Oberman L, Mickey B Clin Neurophysiol. 2025; 170:206-233.

PMID: 39756350 PMC: 11825283. DOI: 10.1016/j.clinph.2024.12.015.


Target engagement of the subgenual anterior cingulate cortex with transcranial temporal interference stimulation in major depressive disorder: a protocol for a randomized sham-controlled trial.

Demchenko I, Rampersad S, Datta A, Horn A, Churchill N, Kennedy S Front Neurosci. 2024; 18:1390250.

PMID: 39268031 PMC: 11390435. DOI: 10.3389/fnins.2024.1390250.


The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.

Yang Y, Shangguan Y, Wang X, Liu R, Shen Z, Tang M Front Neurol. 2024; 14:1307296.

PMID: 38264091 PMC: 10804851. DOI: 10.3389/fneur.2023.1307296.


Limited output transcranial electrical stimulation 2023 (LOTES-2023): Updates on engineering principles, regulatory statutes, and industry standards for wellness, over-the-counter, or prescription devices with low risk.

Bikson M, Ganho-Avila A, Datta A, Gillick B, Joensson M, Kim S Brain Stimul. 2023; 16(3):840-853.

PMID: 37201865 PMC: 10350287. DOI: 10.1016/j.brs.2023.05.008.


High-frequency repetitive transcranial magnetic stimulation alleviates the cognitive side effects of electroconvulsive therapy in major depression.

Chen X, Zhang T, Shan X, Yang Q, Zhang P, Zhu H Front Psychiatry. 2022; 13:1002809.

PMID: 36262627 PMC: 9575950. DOI: 10.3389/fpsyt.2022.1002809.